Valiant Laboratories is a renowned Pharma company that has decided to launch its shares to the public in the form of an IPO. The IPO will be issued on 27 September. The price band of each share will be announced shortly. In the initial public offering, the company is issuing equity shares worth 1.09 crore. Moreover, the offer-for-sale portion is not available in the IPO.
On 26 September for one day, the QIB portion, or the qualified institutional buyers’ portion will be opened. However, on 3rd October the issue will be closed.
For the establishment of manufacturing facilities of speciality chemicals like diketeneand ketene products, Valiant Laboratories has decided to use net fresh issue. The setup will be done at Bharuch, Gujarat, which is owned by Valiant Advanced Sciences, the subsidiary of Mumbai-based Valiant Laboratories. The funds that will be left out will be used for general corporate purposes.
The Promoters
New Mainboard #IPO Announced 📢:
— Paryan Sharma (@ShareMarketNerd) September 20, 2023
VALIANT LABORATORIES IPO
DATE: Sep 27 – Oct 3
ISSUE SIZE: To Be Announced
(100% Fresh Issue)
QUOTA:
QIB: 50%
HNI: 15%
Retail: 35%
GMP: NIL#IPOalert #IPOlisting #IPOmarket #stockmarkets #sharemarketindia #GMP #IPOS2023 #valiantIPO pic.twitter.com/utaQCQKJ79
The bulk drug manufacturing company and the active pharmaceutical ingredient, or API’s full focus is Paracetamol. Thus, it’s owned by the promoters Dhanvallabh Ventures LLP. Dhanvallabh Ventures LLP is the organization that holds 62.5 percent shareholding. Santosh Shantilal Vora and Shantilal Shivji Vora are the promoters who hold a 10.01 percent stake each.
Top Line: Revenue of the Organisation
Valiant Organics is listed on both NSE and BSE. The organization has its manufacturing facility in Palghar, Maharashtra. In the financial year ending in March 2023, the organization recorded a top line of Rs 29 crore. It upsurged by 5.5 percent in the previous year. The operations in revenue increased to Rs 333.9 crore, by 14.5 percent in the same period.
Allotment of Valiant Laboratories IPO
The finalization of the base of IPO allotment of shares will be done by the company by 5 October with NSE. The equity shares have been decided to be transferred to the successful investors’ demat accounts. The unsuccessful investors will get their funds credited directly to their bank accounts by 6 October.
Also Read: WATCH: Reno Air Races 2011 Plane Crash Video Resurfaces ON Internet, Goes Viral
The company will issue its shares for the first time on the stock exchange platforms like NSE and BSE on 9 October with a T+3 settlement, as per the latest guidelines by SEBI.
